Risk factors for liver‐related mortality of patients with hepatitis C virus after sustained virologic response to direct‐acting antiviral agents-Reference-Cited by-同舟云学术

Risk factors for liver‐related mortality of patients with hepatitis C virus after sustained virologic response to direct‐acting antiviral agents

Published:2022-08-26 Issue:10 Volume:6 Page:685-691
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Hattori Nobuhiro¹,Ikeda Hiroki¹^ORCID,Watanabe Tsunamasa¹^ORCID,Satta Yosuke¹,Ehira Takuya¹,Suzuki Tatsuya¹,Kiyokawa Hirofumi¹,Nakahara Kazunari¹,Takahashi Hideaki²,Matsunaga Kotaro³,Matsumoto Nobuyuki²,Yasuda Hiroshi¹^ORCID,Suzuki Michihiro³,Itoh Fumio¹,Tateishi Keisuke¹

Affiliation:

1. Department of Internal Medicine, Division of Gastroenterology and Hepatology St. Marianna University School of Medicine Kawasaki Japan

2. Division of Gastroenterology and Hepatology St. Marianna University Yokohama Seibu Hospital Yokohama Japan

3. Division of Gastroenterology and Hepatology Kawasaki Municipal Tama Hospital Kawasaki Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12805

Reference29 articles.

1. Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals

2. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

3. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

4. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review

5. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life;Tropical Medicine and Infectious Disease;2023-11-18

2. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents;Frontiers in Virology;2023-10-24